Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TherVacB in Chronic Hepatitis B
NCT06513286Phase 2Recruiting
- Start
- Jun 2025
- Primary completion
- Dec 2026
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TherVacB in Chronic Hepatitis B (CHB). Started Jun 2025; status: recruiting.
02
Drugs
TherVacB
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT06513286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06513286.